These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9104928)

  • 1. Treating hypercholesterolemia--without the hype.
    Bassan M; Panush N
    Am J Cardiol; 1997 Apr; 79(7):1001-3. PubMed ID: 9104928
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of statin medications.
    Kaplan RM; Golomb BA
    Am Psychol; 2001 Apr; 56(4):366-7. PubMed ID: 11330239
    [No Abstract]   [Full Text] [Related]  

  • 3. An interactive computer system for formulary management using cost-effectiveness analysis.
    Lee JH; Glick HA; Kinosian B; Schulman KA
    MD Comput; 1995; 12(1):59-65. PubMed ID: 7854081
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reduction of cholesterol and myocardial infarction. Big differences between different groups when it comes to the therapeutic effect].
    Håkansson J
    Lakartidningen; 1997 Dec; 94(49):4619, 4622-3. PubMed ID: 9445934
    [No Abstract]   [Full Text] [Related]  

  • 5. [Summary of the 'Cholesterol' guideline (first revision) of the Dutch College of Family Practice].
    Bonneux L
    Ned Tijdschr Geneeskd; 2000 Apr; 144(18):862-3. PubMed ID: 10816777
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of high blood cholesterol.
    Smith MD; McGhan WF
    Bus Health; 1996 Apr; 14(4):67-8, 70, 72-4. PubMed ID: 10157682
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic aspects of hypercholesterolemia treatment with HMG-CoA reductase inhibitors: a review of recent developments.
    MacNeil P
    Can J Cardiol; 1998 Apr; 14 Suppl A():14A-16A. PubMed ID: 9594928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which lipid-lowering agent should be used first?
    Rutledge DR
    Clin Pharm; 1991 Dec; 10(12):943-5. PubMed ID: 1773584
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effective treatment of hypercholesterolemia.
    Parsons WB
    Arch Intern Med; 1998 Aug 10-24; 158(15):1723-4. PubMed ID: 9701113
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of medicamentous cholesterol control on resources utilization in public health--significance of the Scandinavian Simvastatin Survival Study (4-S Study) for cost control in Swiss health management conditions].
    Szucs TD; Lüscher TF; Gutzwiller F
    Schweiz Med Wochenschr; 1997 Nov; 127(44):1819-23. PubMed ID: 9446200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-benefit analysis of anticholesteremic treatment].
    Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2171-3. PubMed ID: 2505403
    [No Abstract]   [Full Text] [Related]  

  • 12. Lowering cholesterol - a review on the role of plant sterols.
    Clifton P
    Aust Fam Physician; 2009 Apr; 38(4):218-21. PubMed ID: 19350071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals.
    Hirsch M; O'donnell J; Olsson A
    Int J Cardiol; 2005 Oct; 104(3):251-6. PubMed ID: 16186052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
    Liguori E; Sarcinella R
    Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
    [No Abstract]   [Full Text] [Related]  

  • 15. [Broader indication for treatment with statins; the 'heart protection study'].
    Stalenhoef AF; Stuyt PM
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1921-3. PubMed ID: 12404905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
    Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
    Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic principles of cost-benefit analysis in long-term treatment of risk factors].
    Szucs TD; Gutzwiller F
    Schweiz Med Wochenschr; 1998 Dec; 128(49):1958-64. PubMed ID: 9887476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isn't it good if one person out of 600 treated with statins will get better?].
    Molander N
    Lakartidningen; 2004 Jul; 101(28-29):2365. PubMed ID: 15291322
    [No Abstract]   [Full Text] [Related]  

  • 19. [Consequences of cholesterol reduction in cardiovascular diseases. What costs should be allowed to prolong life a year?].
    De Faire U
    Lakartidningen; 1997 Dec; 94(49):4607-9. PubMed ID: 9445932
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating the patient or the population? Part 1. Judging the benefit of treatment of individual patients.
    Heller TD; Heller RF; Pattison S; Fletcher R
    West J Med; 2001 Jul; 175(1):35-7. PubMed ID: 11431400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.